Alaa Alhegaili

Dr. Alaa Alhegaili

Department of Medical Laboratory Sciences, Prince Sattam bin Abdulaziz University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
NSNidhi Sharma
Nidhi Sharma
SBSubhrajit Biswas
Subhrajit Biswas
Noura Al-DayanNoura Al-Dayan
Noura Al-Dayan
AAAlaa Alhegaili
Alaa Alhegaili
MSMaryam Sarwat
Maryam Sarwat
Reactive oxygen species (ROS) are noxious to cells because their increased level interacts with the body’s defense mechanism. These species also cause mutations and uncontrolled cell division, resulting in oxidative stress (OS). Prolonged oxidative stress is responsible for incorrect protein folding in the endoplasmic reticulum (ER), causing a stressful condition, ER stress. These cellular stresses (oxidative stress and ER stress) are well-recognized biological factors that play a prominent role in the progression of hepatocellular carcinoma (HCC). HCC is a critical global health problem and the third leading cause of cancer-related mortality. The application of anti-oxidants from herbal sources significantly reduces oxidative stress. Kaempferol (KP) is a naturally occurring, aglycone dietary flavonoid that is present in various plants (Crocus sativus, Coccinia grandis, Euphorbia pekinensis, varieties of Aloe vera, etc.) It is capable of interacting with pleiotropic proteins of the human body. Efforts are in progress to develop KP as a potential candidate to prevent HCC with no adverse effects. This review emphasizes the molecular mechanism of KP for treating HCC, targeting oxidative stress.

Verified
Journal Article
Open access
PDF file
AAAlaa Alhegaili
Alaa Alhegaili
YJYunhee Ji
Yunhee Ji
NSNicolas Sylvius
Nicolas Sylvius
MBMatthew J. Blades
Matthew J. Blades
MKMahsa Karbaschi
Mahsa Karbaschi
MCMarcus Cooke
Marcus Cooke
The distribution of DNA damage and repair is considered to occur heterogeneously across the genome. However, commonly available techniques, such as the alkaline comet assay or HPLC-MS/MS, measure global genome levels of DNA damage, and do not reflect potentially significant events occurring at the gene/sequence-specific level, in the nuclear or mitochondrial genomes. We developed a method, which comprises a combination of Damaged DNA Immunoprecipitation and next generation sequencing (DDIP-seq), to assess the induction and repair of DNA damage induced by 0.1 J/cm2 solar-simulated radiation at the sequence-specific level, across both the entire nuclear and mitochondrial genomes. DDIP-seq generated a genome-wide, high-resolution map of cyclobutane thymine dimer (T<>T) location and intensity. In addition to being a straightforward approach, our results demonstrated a clear differential distribution of T<>T induction and loss, across both the nuclear and mitochondrial genomes. For nuclear DNA, this differential distribution existed at both the sequence and chromosome level. Levels of T<>T were much higher in the mitochondrial DNA, compared to nuclear DNA, and decreased with time, confirmed by qPCR, despite no reported mechanisms for their repair in this organelle. These data indicate the existence of regions of sensitivity and resistance to damage formation, together with regions that are fully repaired, and those for which > 90% of damage remains, after 24 h. This approach offers a simple, yet more detailed approach to studying cellular DNA damage and repair, which will aid our understanding of the link between DNA damage and disease.

22 April 2025 in Molecular Systems Design & Engineering
Verified
Journal Article
Closed access
PDF file
EKElham Mohammed Khatrawi
Elham Mohammed Khatrawi
Syed Luqman AliSyed Luqman Ali
Syed Luqman Ali
SASyed Yasir Ali
Syed Yasir Ali
AAAigul Abduldayevna Abduldayeva
Aigul Abduldayevna Abduldayeva
AAAlaa Alhegaili
Alaa Alhegaili
A multi-epitope vaccine targeting UPF0721 of Salmonella enterica was designed using immunoinformatics and molecular simulations, offering a promising strategy against meningitis-causing bacterial infections.

7 April 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SYSaima Younas
Saima Younas
ANAtiqa Nosheen
Atiqa Nosheen
ZMZaryab Ikram Malik
Zaryab Ikram Malik
NHNazim Hussain
Nazim Hussain
MKMuhammad Umer Khan
Muhammad Umer Khan
Hafiz Muhammad HammadHafiz Muhammad Hammad
Hafiz Muhammad Hammad

13 July 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KEKholoud A. Elzanaty
Kholoud A. Elzanaty
GOGamal Abd elhay Omran
Gamal Abd elhay Omran
Ehab Kotb ElmahallawyEhab Kotb Elmahallawy
Ehab Kotb Elmahallawy
AAAshraf Albrakati
Ashraf Albrakati
ASAyman Saleh
Ayman Saleh
TOTarek M. Okda
Tarek M. Okda
There is a growing interest in discovering natural sources of anti-cancer drugs. Sesamol (SES) is a phenolic compound with antitumor effects. The present study aimed to investigate the anticancer properties of SES and its nano-suspensions (SES-NS) combined with Epirubicin (EPI) in breast cancer (BC) using mice bearing a solid Ehrlich tumor. The study involved 35 female albino mice and investigated the effects of SES and EPI on tumor growth, proliferation, apoptosis, autophagy, angiogenesis, and oxidative stress. Methods including ELISA, qRT-PCR, and immunohistochemistry were utilized. The findings revealed reductions in tumor growth and proliferation using SES either alone or combined and evidenced by decreased AKT (AKT Serine/Threonine kinase1) levels, angiogenesis indicated by lower levels of VEGFR (vascular endothelial growth factor), and apoptosis demonstrated by elevated caspase3 and BAX levels. Furthermore, autophagy increased and was indicated by increased levels of beclin1 and lc3, along with decreased oxidative stress as evidenced by elevated TAC (total antioxidant capacity) and reduced MDA (malondialdehyde) levels. Interestingly, SES-NS demonstrated more significant effects at lower doses. In summary, this study underscores the potential of SES as a promising agent for BC treatment. Moreover, SES-NS potentiated the beneficial effects of EPI while mitigating its adverse effects.

20 October 2024 in Physiotherapy Research International
Verified
Journal Article
Closed access
AAAlshimaa R. Azab
Alshimaa R. Azab
RERagab K. Elnaggar
Ragab K. Elnaggar
DHDalia G Hamouda
Dalia G Hamouda
GAGhfren S. Aloraini
Ghfren S. Aloraini
AAAlaa Alhegaili
Alaa Alhegaili
AEAhmed A. Elshehawy
Ahmed A. Elshehawy